Hoppa till innehållet

OMXSPI+1,18%

S&P 500+0,30%

FTSE 100+0,05%

DAX+0,33%

NIKKEI+0,73%
Correction: BrainCool AB (publ) - Financial Report for Q1 2024

There is an error in Business Segment page 5. It is stated that the deliveries of the 350 Systems to ZOLL® will be carried out over 12-18 months. The correct fact is a period over 24 months.

Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
E-mail: jon.berg@braincool.se

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

This information is information that BrainCool is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-04-15 19:03 CEST.

Attachments
Q1 2024 Report Corrected

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera